F. Greco

发表

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

J. Hainsworth, G. Varadhachary, M. Raber, 2013, International Journal of Clinical Oncology.

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.

L. Einhorn, F. Greco, P. Loehrer, 1987, The New England journal of medicine.

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.

L. Einhorn, F. Greco, P. Loehrer, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancoast's syndrome and small cell lung cancer.

J. Hainsworth, David H. Johnson, D. Johnson, 1982, Chest.

Prognostic factors for favorable outcome in disseminated germ cell tumors.

L. Einhorn, F. Greco, R. Birch, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

P. Benotti, S. Wallach, C. Arkin, 1990, Annals of internal medicine.

Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus.

F. Greco, A. List, L. Vogler, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer

J. Hainsworth, H. Burris, D. Yardley, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome.

J. Hainsworth, W. Vaughn, F. Greco, 1986, Annals of internal medicine.

Overview of patient management and future directions in unknown primary carcinoma.

G. Varadhachary, F. Greco, 2009, Seminars in oncology.

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

N. Pavlidis, G. Pentheroudakis, K. Fizazi, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

J. Hainsworth, H. Burris, M. Thomas, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumors of unknown origin

J. Hainsworth, F. Greco, John D. Hainsworth, 1992, CA: a cancer journal for clinicians.

Phase I/II trial of paclitaxel by 1‐hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

J. Hainsworth, H. Burris, F. Greco, 1999, Cancer.

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.

Suzanne F. Jones, P. Sabbatini, H. Burris, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.

J. Hainsworth, D. Spigel, F. Greco, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Tumor Profiling in the Diagnosis of Patients with Carcinoma of Unknown Primary Site: Retrospective Evaluation of Gene Microarray Assay

J. Hainsworth, M. Halks-Miller, W. D. Henner, 2011 .

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site

J. Hainsworth, H. Burris, D. Spigel, 2010, Cancer.

Paclitaxel/Carboplatin/Etoposide Versus Gemcitabine/Irinotecan in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site: A Randomized, Phase III Sarah Cannon Oncology Research Consortium Trial

J. Hainsworth, D. Spigel, F. Greco, 2010, Cancer journal.

Concurrent chemoradiation followed by esophageal resection vs chemoradiation alone for localized esophageal cancer

J. Hainsworth, R. Hermann, D. Spigel, 2007 .

Preoperative Therapy with Concurrent Paclitaxel/Carboplatin/Infusional 5‐FU and Radiation Therapy in Locoregional Esophageal Cancer: Final Results of a Minnie Pearl Cancer Research Network Phase II Trial

J. Hainsworth, K. Yost, J. L. Davis, 2003, Cancer journal.

Paclitaxel, carboplatin, and long‐term continuous infusion of 5‐fluorouracil in the treatment of advanced squamous and other selected carcinomas

J. Hainsworth, H. Burris, F. Greco, 2001, Cancer.

The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer.

J. Hainsworth, D. Johnson, F. Greco, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.

J. Hainsworth, C. McKay, F. Greco, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.

J. Hainsworth, F. Greco, J. Gray, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.

J. Hainsworth, F. Greco, 1994, Seminars in oncology.

Emerging role of topotecan in first-line therapy of small-cell lung cancer.

J. Hainsworth, F. Greco, 2003, Clinical lung cancer.

Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.

J. Reeves, J. Hainsworth, H. Burris, 2010, Clinical lung cancer.

Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.

J. Hainsworth, J. Bendell, H. Burris, 2010, Clinical advances in hematology & oncology : H&O.

Diagnosis: Improved diagnosis, therapy and outcomes for patients with CUP

F. Greco, 2017, Nature Reviews Clinical Oncology.

Poorly Differentiated Neoplasms of Unknown Primary Site: Diagnostic Usefulness of a Molecular Cancer Classifier Assay

J. Hainsworth, D. Spigel, F. Greco, 2015, Molecular Diagnosis & Therapy.

Cancer of unknown primary site: still an entity, a biological mystery and a metastatic model

F. Greco, 2013, Nature Reviews Cancer.

Topotecan as first-line therapy for small cell lung cancer.

F. Greco, 2003, Lung cancer.

Current Management and New Leads in Small Cell Lung Cancer

J. Hainsworth, F. Greco, 1999 .

Adriamycin and radiation: synegistic cardiotoxicity.

H. Brereton, F. Greco, T. Pomeroy, 1975, Annals of internal medicine.

Combination chemotherapy of malignant mesothelioma with cyclophosphamide, adriamycin and vincristine

P. Beatty, F. Greco, R. Richardson, 1980, Cancer Chemotherapy and Pharmacology.

Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.

J. Hainsworth, H. Burris, D. Yardley, 2007, Clinical lung cancer.

Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial.

J. Hainsworth, J. Sosman, L. Hart, 2007, Clinical genitourinary cancer.

Combined Modality Treatment With Chemotherapy, Radiation Therapy, Bevacizumab, and Erlotinib in Patients With Locally Advanced Squamous Carcinoma of the Head and Neck: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

J. Hainsworth, D. Spigel, F. Greco, 2011, Cancer journal.

Phase 1 Results From a Study of Romidepsin in Combination With Gemcitabine in Patients With Advanced Solid Tumors

Suzanne F. Jones, H. Burris, J. Infante, 2012, Cancer investigation.

Germ cell neoplasms and other malignancies of the mediastinum.

J. Hainsworth, F. Greco, 2001, Cancer treatment and research.

Small-cell lung cancer

F. Greco, R. Oldham, Francesco Greco, 1979, Cancer Chemotherapy and Pharmacology.

Postchemotherapy resection of residual tumor in limited stage small cell lung cancer.

L. Einhorn, D. Johnson, F. Greco, 1987, Chest.

Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limited-stage small-cell lung cancer (LS-SCLC)

J. Hainsworth, L. Hart, H. Burris, 2008 .

Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.

F. Greco, R. Birch, S. Wolff, 1986, Cancer treatment reports.

Limited value of CT brain scans in the staging of small cell lung cancer.

W. W. Windham, D. Johnson, F. Greco, 1982, AJR. American journal of roentgenology.

Adriamycin and enhanced radiation reaction in normal esophagus and skin.

H. Brereton, F. Greco, R. Johnson, 1976, Annals of internal medicine.

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

J. Hainsworth, H. Burris, D. Spigel, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancer.

J. Hainsworth, H. Burris, D. Spigel, 2011, Clinical lung cancer.

Single Agent Vinflunine in the Salvage Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Trial of the Sarah Cannon Research Consortium

J. Hainsworth, H. Burris, D. Spigel, 2010, Cancer investigation.

A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer

Suzanne F. Jones, J. Hainsworth, H. Burris, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II Trial of Vinflunine in Relapsed Small Cell Lung Cancer

J. Hainsworth, H. Burris, D. Spigel, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.

J. Hainsworth, H. Burris, D. Yardley, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

J. Hainsworth, H. Burris, D. Spigel, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2009, Clinical breast cancer.

A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2008, Clinical breast cancer.

Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.

J. Hainsworth, H. Burris, J. Infante, 2009, Clinical breast cancer.

Phase I Study of JM-216 (an Oral Platinum Analogue) in Combination with Paclitaxel in Patients with Advanced Malignancies

Suzanne F. Jones, J. Hainsworth, H. Burris, 2002, Investigational New Drugs.

Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, R. Hermann, F. Greco, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.

J. Hainsworth, F. Greco, D. Thompson, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2005, Clinical lung cancer.

A phase I dose-escalation study of NK012

Suzanne F. Jones, H. Burris, J. Infante, 2008 .

Bevacizumab and erlotinib in the treatment of patients with metastatic renal carcinoma (RCC): Update of a phase II multicenter trial

J. Hainsworth, J. Sosman, K. Yost, 2005 .

Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.

J. Hainsworth, W. Grosh, L. Burnett, 1988, Annals of internal medicine.

Lung cancer in Hodgkin's disease: association with previous radiotherapy.

F. Greco, A. List, D. Doll, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignancies.

Suzanne F. Jones, H. Burris, J. Infante, 2010, The Oncologist.

Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.

N. Senzer, J. Nemunaitis, M. Morse, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Poorly differentiated lung cancer.

F. Greco, R. Oldham, M. Matthews, 1982, Seminars in oncology.

Small cell lung cancer: progress and perspectives.

L. Einhorn, F. Greco, R. Oldham, 1978, Seminars in oncology.

Vandetanib versus erlotinib in patients with advanced non-small cell lung cancer (NSCLC) after failure of at least one prior cytotoxic chemotherapy: A randomized, double-blind phase III trial (ZEST).

Michael Thomas, S. Thongprasert, P. Sunpaweravong, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck

J. Hainsworth, H. Burris, D. Spigel, 2009, Cancer.

High-dose pilot studies in extensive-stage small-cell lung cancer.

J. Hainsworth, D. Johnson, F. Greco, 1986, Seminars in oncology.

Appetite stimulation with megestrol acetate in cachectic cancer patients.

F. Greco, J. Aisner, N. Tchekmedyian, 1986, Seminars in oncology.

Biology and Management of Lung Cancer

F. Greco, 1983, Cancer Treatment and Research.

Lung cancer after exposure to radon daughters.

F. Greco, A. List, 1984, The New England journal of medicine.

Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.

J. Hainsworth, M. Thomas, D. Johnson, 1992, Seminars in oncology.

Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non‐small cell lung cancer

J. Hainsworth, J. Strupp, F. Greco, 1991, Cancer.

Evolving role of oral chemotherapy for the treatment of patients with neoplasms.

F. Greco, 1998, Oncology.

Future directions for etoposide therapy.

F. Greco, 1991, Cancer.

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma

J. Hainsworth, H. Burris, F. Greco, 2000, Cancer.

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone‐refractory prostate carcinoma

J. Hainsworth, F. Greco, R. Steis, 2003, Cancer.

Papillary Renal Carcinoma Presenting as a Cancer of Unknown Primary (CUP) and Diagnosed through Gene Expression Profiling

F. Greco, S. Sorscher, 2012, Case Reports in Oncology.

Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, F. Greco, L. Kalman, 2005, Gynecologic oncology.

Testicular function following combination chemotherapy with cis-platin, vinblastine, and bleomycin.

J. Hainsworth, D. Johnson, F. Greco, 1984, Medical and pediatric oncology.

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.

J. Hainsworth, H. Burris, F. Greco, 2000, Blood.

Weekly docetaxel with either gemcitabine or vinorelbine as second‐line treatment in patients with advanced nonsmall cell lung carcinoma

J. Hainsworth, H. Burris, F. Billings, 2001, Cancer.

Improved NSCLC cure rates now certain

F. Greco, 2004 .

Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis.

J. Hainsworth, F. Greco, A. List, 1986, Annals of internal medicine.

Metastatic breast cancer confined to the skeletal system: An indolent disease☆

J. Hainsworth, F. Greco, David H. Johnson, 1986 .

Maintenance etidronate in the prevention of malignancy-associated hypercalcemia.

A. Benson, E. Siris, J. Schiller, 1987, Archives of internal medicine.

Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes.

J. Hainsworth, B. McAneny, F. Greco, 1999, American journal of clinical oncology.

Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses

J. Hainsworth, B. McAneny, F. Greco, 1997, Bone Marrow Transplantation.

High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers

J. Hainsworth, F. Greco, L. Schwartzberg, 1997, Bone Marrow Transplantation.

Etoposide: twenty years later.

J. Hainsworth, F. Greco, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.

J. Hainsworth, D. Johnson, F. Greco, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.

J. Hainsworth, F. Greco, M. Schreeder, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inflammatory carcinoma of the breast. Clinical review and summary of the Vanderbilt experience with multi-modality therapy.

J. Hainsworth, D. Page, D. Johnson, 1985, The American journal of medicine.

The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluation.

J. Hainsworth, R. Prager, H. Bender, 1984, The Annals of thoracic surgery.

Reflectance spectroscopy of clotting blood: a description of the time-dependent behavior.

F. Greco, 2004, Archives of pathology & laboratory medicine.

Favorable prognosis of brain metastases in small cell lung cancer.

D. Johnson, F. Greco, K. Hande, 1987, Annals of internal medicine.

Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary A C

M. Overman, G. Varadhachary, A. Matamoros, 2021 .

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

J. Hainsworth, H. Burris, F. Greco, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, M. Thomas, F. Greco, 1999, The cancer journal from Scientific American.

Lactic acidosis associated with metastatic osteogenic sarcoma.

P. Stacpoole, F. Greco, M. Lichtenstein, 1981, Southern medical journal.

Pneumocystis carinii pneumonia: a complication of Cushing's syndrome.

F. Greco, L. Anthony, 1981, Annals of internal medicine.

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

J. Hainsworth, M. Thomas, F. Greco, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.

J. Hainsworth, H. Burris, F. Greco, 2001, Seminars in oncology.

Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.

J. Hainsworth, M. Thomas, D. Johnson, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial.

L. Einhorn, A. Bartolucci, F. Greco, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.

F. Greco, R. Oldham, J. Knost, 1981, Cancer treatment reports.

Chronic oral etoposide in the treatment of lung cancer.

J. Hainsworth, F. Greco, K. Hande, 1992, Seminars in oncology.

Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC).

J. Hainsworth, J. Sosman, D. Spigel, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site.

J. Hainsworth, F. Greco, W. Lennington, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity.

J. Hainsworth, D. Johnson, F. Greco, 1988, Annals of internal medicine.

Managing carcinomas of unknown primary site.

J. Hainsworth, F. Greco, 1988, Oncology.

Paclitaxel-based therapy in non-small-cell lung cancer: improved third generation chemotherapy.

J. Hainsworth, F. Greco, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, H. Burris, D. Yardley, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Appetite stimulation and weight gain with megestrol acetate.

H. Parnes, F. Greco, J. Aisner, 1990, Seminars in oncology.

Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer

Suzanne F. Jones, J. Hainsworth, H. Burris, 2010 .

Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma.

J. Hainsworth, W. Grosh, L. Burnett, 1989, Annals of internal medicine.

Induction chemotherapy + gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients (pts) with locally advanced squamous carcinoma of the head and neck: A phase I/II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, D. Spigel, F. Greco, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mitoxantrone, 5‐fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5‐fluorouracil (CMF) in first‐line chemotherapy for patients with metastatic breast carcinoma

J. Hainsworth, F. Greco, R. Birch, 1997 .

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.

J. Hainsworth, F. Greco, R. Birch, 1997, Cancer.

Development and validation of a novel nomogram for individualized prediction of survival in cancer of unknown primary (CUP)

M. Overman, G. Varadhachary, A. Matamoros, 2021 .

Reflectance Changes in Clotting Native Blood: Evidence of a Red Cell Process

F. Greco, 2008, Pathophysiology of Haemostasis and Thrombosis.

Bevacizumab, erlotinib, and imatinib in the treatment of patients with advanced renal cell carcinoma: Update of a multicenter phase II trial.

J. Hainsworth, J. Sosman, L. Hart, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium.

I. Flinn, J. Hainsworth, H. Burris, 2010, Clinical lymphoma, myeloma & leukemia.

Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.

J. Hainsworth, D. Spigel, F. Greco, 2009, Clinical lymphoma & myeloma.

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first‐line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

J. Hainsworth, D. Spigel, F. Greco, 2008, Cancer.

Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium

J. Hainsworth, K. Yost, F. Greco, 2005, Cancer.

The Role of Hexamethylmelamine in the Combination Chemotherapy of Advanced Ovarian Cancer: A Comparison of Hexamethylmelamine, Cyclophosphamide, Doxorubicin, and Cisplatin (H‐CAP) Versus Cyclophosphamide, Doxorubicin, and Cisplatin (CAP)

J. Hainsworth, H. Jones, L. Burnett, 1990, American journal of clinical oncology.

A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma

J. Hainsworth, J. Sosman, Douglas B. Johnson, 2016, Pigment cell & melanoma research.

Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer.

J. Hainsworth, H. Burris, F. Greco, 2000, Oncology.

Chemotherapy of Advanced Non‐Small‐Cell Lung Cancer: A Randomized Trial of Three cis‐Platin‐Based Chemotherapy Regimens

J. Hainsworth, D. Johnson, F. Greco, 1989, American journal of clinical oncology.

Gemcitabine in the Second-Line Therapy of Patients with Carcinoma of Unknown Primary Site: A Phase II Trial of the Minnie Pearl Cancer Research Network

J. Hainsworth, H. Burris, J. Bramham, 2001, Cancer investigation.

The PI3K/mTOR inhibitor BEZ235 given twice daily for the treatment of patients (pts) with advanced solid tumors.

Suzanne F. Jones, J. Bendell, H. Burris, 2012 .

Systematic review of the CUP trials characteristics and perspectives for next-generation studies.

N. Pavlidis, S. Boussios, F. Greco, 2022, Cancer treatment reviews.

The role of site-specific therapy for cancers of unknown of primary: A meta-analysis.

E. V. Van Allen, T. Choueiri, N. Pavlidis, 2020, European journal of cancer.

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

N. Pavlidis, G. Pentheroudakis, K. Fizazi, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin.

J. Hainsworth, R. Hermann, H. Burris, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase I Trial to Determine the Safety of Imatinib in Combination With Vatalanib in Patients With Advanced Malignancies

Suzanne F. Jones, J. Hainsworth, H. Burris, 2011, Cancer investigation.

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.

L. Einhorn, E. Crawford, A. Bartolucci, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung.

J. Hainsworth, F. Greco, K. Hande, 1983, Cancer treatment reports.

Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study

J. Hainsworth, F. Greco, K. Hande, 1994, Cancer.

Chronic etoposide administration: overview of clinical experience.

F. Greco, 1993, Cancer treatment reviews.

Advanced Minimal Residual Ovarian Carcinoma: Abdominopelvic Irradiation Following Combination Chemotherapy

J. Hainsworth, L. Burnett, H. Jones, 1983, Obstetrics and gynecology.

Abdominopelvic Computed Tomography: Evaluation in Patients Undergoing Second‐Look Laparotomy for Ovarian Carcinoma

W. Grosh, L. Burnett, H. Jones, 1985, Obstetrics and gynecology.

Chronic daily administration of oral etoposide in refractory lymphoma.

J. Hainsworth, D. Johnson, F. Greco, 1990, European journal of cancer.

Chronic daily administration of oral etoposide--a phase I trial.

J. Hainsworth, D. Johnson, F. Greco, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late recurrences in long‐term survivors of germ cell neoplasms

J. Hainsworth, F. Greco, M. Deleo, 1988, Cancer.

Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.

J. Hainsworth, L. Einhorn, F. Greco, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advanced extragonadal germ-cell tumors. Successful treatment with combination chemotherapy.

J. Hainsworth, L. Einhorn, F. Greco, 1982, Annals of internal medicine.

Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study.

J. Hainsworth, F. Greco, K. Hande, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma

J. Hainsworth, F. Greco, S. Stroup, 1996, Cancer.

High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.

J. Hainsworth, F. Greco, S. Wolff, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte‐colony‐ stimulating factor: an analysis of 497 patients

J. Hainsworth, J. Foster, F. Greco, 1997, Transfusion.

Malignant mixed mesodermal tumors of the uterus and ovary treated with cisplatin-based combination chemotherapy.

W. Grosh, L. Burnett, H. Jones, 1986, Gynecologic oncology.

High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.

J. Hainsworth, W. Grosh, L. Burnett, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer.

J. Hainsworth, F. Greco, L. Schwartzberg, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.

J. Hainsworth, F. Greco, C. Scroggin, 2003, Clinical lymphoma.

Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma

J. Hainsworth, H. Burris, F. Greco, 2002 .

Adjuvant chemoimmunotherapy stage i/ii malignant melanoma

F. Greco, R. Oldham, J. Knost, 1982, Journal of surgical oncology.

Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.

J. Hainsworth, F. Greco, J. Greer, 1993, Leukemia & lymphoma.

Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy.

J. Hainsworth, D. Johnson, F. Greco, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer and the kidney: Renal complications of neoplasms

F. Greco, R. Oldham, K. Hande, 1981 .

Cancer and the kidney: complications of neoplasms.

F. Greco, R. Oldham, K. Hande, 1981, The American journal of medicine.

J. Hainsworth, F. Greco, L. Schwartzberg, 1997, Bone Marrow Transplantation.

Treatment of oat cell carcinoma of the lung: complete remissions, acceptable complications, and improved survival.

F. Greco, R. Oldham, R. Richardson, 1978, British medical journal.

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive‐stage small cell lung cancer

J. Hainsworth, F. Greco, K. Hande, 1992, Cancer.

Combined small-cell and non-small-cell lung cancer.

J. Hainsworth, D. Johnson, F. Greco, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

C. Perez, L. Einhorn, R. Vollmer, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.

J. Hainsworth, D. Johnson, F. Greco, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel (Taxol): phase I/II trial comparing 1-hour infusion schedules.

J. Hainsworth, F. Greco, 1994, Seminars in oncology.

Complications of treatment of small cell carcinoma of the lung.

P. Postmus, J. Klastersky, F. Greco, 1983, Cancer treatment reports.

Tumor products and potential markers in small cell lung cancer.

G. W. Liddle, F. Greco, R. Oldham, 1978, Seminars in oncology.

Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.

J. Hainsworth, F. Greco, J. Greer, 1986, Cancer treatment reports.

Bevacizumab, erlotinib, and imatinib in the treatment of patients (pts) with advanced renal cell carcinoma (RCC): A Minnie Pearl Cancer Research Network phase I/II trial

J. Hainsworth, J. Sosman, L. Hart, 2005 .

Gemcitabine and vinorelbine in the second‐line treatment of nonsmall cell lung carcinoma patients

J. Hainsworth, H. Burris, F. Greco, 2000, Cancer.

An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with hormone refractory prostate cancer (HRPC)

B. Somer, T. Kuzel, B. Curti, 2008 .

Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining.

D. Johnson, F. Greco, E. Wright, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly combination chemotherapy with docetaxel and gemcitabine as first‐line treatment for elderly patients and patients with poor performance status who have extensive‐stage small cell lung carcinoma

J. Hainsworth, F. Greco, R. Drengler, 2004, Cancer.

Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies

J. Hainsworth, F. Greco, S. Utley, 2004, Investigational New Drugs.

Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer.

C. Perez, L. Einhorn, A. Bartolucci, 1990, Annals of internal medicine.

Management of patients with cancer of unknown primary site.

J. Hainsworth, F. Greco, 2000, Oncology.

A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.

S. Jones, J. Durant, F. Greco, 1982, Cancer treatment reviews.

Weekly D ocetaxel i n t he T reatment o f E lderly P atients With A dvanced B reast C ancer: A M innie P earl C ancer Research N etwork P hase I I T rial

J. Hainsworth, H. Burris, D. Yardley, 2001 .

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.

J. Hainsworth, D. Johnson, F. Greco, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Curative Combination Chemotherapy for Patients with Advanced Poorly Differentiated Carcinoma of Unknown Primary Site

J. Hainsworth, F. Greco, Teddi W. Dial, 1988, American journal of clinical oncology.

Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapy.

J. Hainsworth, F. Greco, G. Gray, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The unrecognized extragonadal germ cell cancer syndrome.

F. Greco, R. Oldham, J. T. Forbes, 1981, Annals of internal medicine.

Non-Curative Chemotherapy for Patients with Unknown Primary Cancers

J. Hainsworth, F. Greco, 1998 .

A randomized, multicenter phase III trial comparing doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for high-risk breast cancer

J. Hainsworth, N. Robert, J. O’Shaughnessy, 2007 .

Chronic etoposide schedules in the treatment of non-Hodgkin's lymphoma.

J. Hainsworth, D. Johnson, F. Greco, 1992, Seminars in oncology.

First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial

J. Hainsworth, H. Burris, D. Yardley, 2004 .

First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, H. Burris, D. Yardley, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Current concepts in cancer: small-cell lung cancer.

F. Greco, R. Oldham, 1979, The New England journal of medicine.

Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).

H. Brereton, D. Rodbard, F. Greco, 1976, Cancer treatment reports.

Weekly administration of docetaxel (Taxotere): summary of clinical data.

J. Hainsworth, H. Burris, F. Greco, 1999, Seminars in oncology.

Prolonged administration of low-daily-dose etoposide: a superior dosing schedule?

J. Hainsworth, F. Greco, 2004, Cancer Chemotherapy and Pharmacology.

A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.

J. Hainsworth, F. Greco, J. Gray, 2004, Clinical lung cancer.

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.

J. Hainsworth, F. Greco, 1993, Seminars in oncology.

Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site.

J. Hainsworth, F. Greco, G. Garrow, 1993, Seminars in oncology.

Poorly differentiated neoplasms and tumors of unknown origin: introduction.

F. Greco, R. Oldham, M. Fer, 1982, Seminars in oncology.

Etoposide kinetics in patients with obstructive jaundice.

J. Hainsworth, G. Reed, D. Johnson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors

Suzanne F. Jones, M. von Mehren, H. Burris, 2009, Clinical Cancer Research.

Cancer and the kidney: Renal complications of neoplasms

F. Greco, R. Oldham, K. Hande, 1981 .

Weekly docetaxel and bortezomib as first-line treatment for patients with hormone-refractory prostate cancer: a Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, D. Spigel, F. Greco, 2007, Clinical genitourinary cancer.

Cushing's syndrome with small cell carcinoma of the uterine cervix.

L. Burnett, F. Greco, R. Oldham, 1980, The American journal of medicine.

A phase II trial of preoperative chemoradiation therapy plus bevacizumab and erlotinib in the treatment of localized esophageal cancer.

J. Hainsworth, J. Bendell, H. Burris, 2010 .

High-dose etoposide: from phase I to a component of curative therapy.

J. Hainsworth, F. Greco, S. Wolff, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Introduction: unknown primary cancer.

J. Hainsworth, F. Greco, 2009, Seminars in oncology.

Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer.

P. Bunn, L. Einhorn, F. Greco, 1986, Seminars in oncology.

Phase II study of bevacizumab and everolimus (RAD001) in the treatment of advanced renal cell carcinoma (RCC)

J. Hainsworth, H. Burris, D. Yardley, 2008 .

A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC).

F. Greco, R. Birch, T. Goggins, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin plus etoposide in small cell lung cancer.

L. Einhorn, F. Greco, P. Loehrer, 1988, Seminars in oncology.

Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, H. Burris, F. Greco, 2002, Cancer.

Small cell lung cancer: Complete remission and improved survival

F. Greco, R. Oldham, J. Snell, 1979 .

Human natural cell-mediated cytotoxicity

F. Greco, R. Oldham, J. T. Forbes, 1981, Cancer Immunology, Immunotherapy.

Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.

J. Hainsworth, W. Grosh, F. Greco, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Morphologic Changes in Small Cell Lung Cancer

W. Grosh, F. Greco, M. Fer, 1983 .

Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer.

F. Greco, R. Oldham, K. Hande, 1982, The American journal of medicine.

NATURAL CELL-MEDIATED CYTOTOXICITY IN HUMAN TUMOR PATIENTS

F. Greco, R. Oldham, J. T. Forbes, 1980 .

Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.

J. Hainsworth, S. Jones, R. Mennel, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

J. Hainsworth, J. Kuttesch, D. Johnson, 1989, Cancer research.

Primary Germ Cell Tumors of the Thorax

J. Hainsworth, F. Greco, 2003 .

Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.

J. Hainsworth, F. Greco, E. Raefsky, 1995, The cancer journal from Scientific American.

Extrahepatic biliary obstruction caused by small-cell lung cancer.

J. Hainsworth, D. Johnson, F. Greco, 1985, Annals of internal medicine.

Cancer Therapy: Clinical A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors

Suzanne F. Jones, M. Mehren, H. Burris, 2009 .

Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors

Suzanne F. Jones, M. Mehren, H. Burris, 2009 .

Paclitaxel for limited-stage small-cell lung cancer.

J. Hainsworth, F. Greco, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Spinal cord compression.

F. Greco, 1977, Journal of the Tennessee Medical Association.

Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.

J. Hainsworth, F. Greco, A. Meluch, 1997, Seminars in oncology.

Prolonged intermittent oral topotecan in patients with refractory and/or advanced malignancies

Suzanne F. Jones, J. Hainsworth, H. Burris, 2004 .

Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, F. Greco, M. Grimaldi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary brain lymphoma in the immunocompetent host: relation to Epstein-Barr virus.

D. Volsky, D. Purtilo, D. Johnson, 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Treatment of carcinoma of unknown primary site (CUP) directed by molecular profiling diagnosis: A prospective, phase II trial.

M. Erlander, J. Hainsworth, C. Schnabel, 2010 .

Combination chemotherapy with oral etoposide.

D. Johnson, F. Greco, K. Hande, 1992, Seminars in oncology.

Testicular germ cell neoplasms.

J. Hainsworth, F. Greco, 1983, The American journal of medicine.

Diagnostic and therapeutic management of cancer of an unknown primary.

J. Hainsworth, N. Pavlidis, F. Greco, 2003, European journal of cancer.

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.

G R Wilkinson, F. Greco, G. Wilkinson, 1984, Cancer research.

High-dose etoposide (VP-16) in small-cell lung cancer.

J. Hainsworth, F. Greco, K. Hande, 1985, Seminars in oncology.

lymphoma: preliminary observations combination chemotherapy on posttherapy fertility in male patients with Effect of a luteinizing hormone releasing hormone agonist given during

W. Vale, F. Greco, J. Rivier, 2011 .

Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations

J. Hainsworth, W. Vale, F. Greco, 1985 .

Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations.

J. Hainsworth, W. Vale, D. Johnson, 1985, Blood.

Cancer of unknown primary site.

W. E. Jordan, J. Hainsworth, P. Engstrom, 2010, Seminars in oncology.

The role of maintenance therapy in disseminated testicular cancer.

L. Einhorn, M. Troner, F. Greco, 1981, The New England journal of medicine.

Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.

J. Hainsworth, D. Johnson, F. Greco, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The extragonadal germ cell cancer syndrome.

F. Greco, R. Oldham, M. Fer, 1982, Seminars in oncology.

Human chorionic gonadotropin production by colon carcinoma. Biochemical heterogeneity and identification of a chemotherapy‐sensitive cell subpopulation

J. Hainsworth, F. Greco, 1985, Cancer.

Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience.

L. Einhorn, F. Greco, P. Loehrer, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extragonadal germ cell tumors and unrecognized germ cell tumors.

J. Hainsworth, F. Greco, 1992, Seminars in oncology.

Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma.

J. Hainsworth, H. Burris, D. Yardley, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP).

J. Hainsworth, L. Burnett, H. Jones, 1983, Cancer treatment reports.

Small cell carcinoma of the lung.

L. Einhorn, D. Johnson, F. Greco, 1986, Critical reviews in oncology/hematology.

Atypical carcinoid of the lung. A distinct clinicopathologic entity.

D. Johnson, F. Greco, W. Macon, 1988, Chest.

Treatment of patients with cancer of an unknown primary site.

J. Hainsworth, F. Greco, F A Greco, 1993, The New England journal of medicine.

Combination intraventricular chemotherapy for meningeal neoplasia.

J. Hainsworth, F. Greco, L. Giannone, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of high‐dose cytarabine

F. Greco, K. Hande, R. Stein, 1982, Clinical pharmacology and therapeutics.

Induction Paclitaxel, Carboplatin, and Infusional 5‐FU Followed by Concurrent Radiation Therapy and Weekly Paclitaxel/Carboplatin in the Treatment of Locally Advanced Head and Neck Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network

James K. Ellis, J. Hainsworth, H. Burris, 2002, Cancer journal.

Chemotherapy of small-cell lung cancer.

J. Hainsworth, David H. Johnson, D. Johnson, 1985, Seminars in oncology.

Novel Diagnostic and Therapeutic Strategies in the Management of Patients with Cancers of Unknown Primary Site

J. Hainsworth, F. Greco, 2016 .

A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors

Suzanne F. Jones, J. Bendell, H. Burris, 2015, Investigational new drugs.

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.

N. Pavlidis, G. Pentheroudakis, F. Greco, 2009, Cancer treatment reviews.

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

Kenneth R Hess, K. Hess, Yixin Wang, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer.

J. Hainsworth, G. Wampler, M. Seyedsadr, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bioavailability of low-dose oral etoposide.

J. Hainsworth, D. Johnson, F. Greco, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Other Cancers Cancer of Unknown Primary Site 113

J. Hainsworth, F. Greco, 2014 .

Neoplasms of Unknown Primary Site

J. Hainsworth, F. Greco, 2002 .

Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.

J. Hainsworth, D. Spigel, F. Greco, 2013, Journal of the National Cancer Institute.

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

J. Hainsworth, D. Spigel, F. Greco, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors.

N. Pavlidis, F. Greco, 2009, Seminars in oncology.

Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine.

J. Hainsworth, F. Greco, 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care

J. Hainsworth, F. Greco, John D. Hainsworth, 2014, Virchows Archiv.

A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.

M. Erlander, J. Hainsworth, C. Schnabel, 2012, Clinical colorectal cancer.

Molecular tumor profiling (MTP) in cancer of unknown primary site (CUP): A complement to standard pathologic diagnosis.

J. Hainsworth, D. Spigel, F. Greco, 2011, Journal of Clinical Oncology.

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.

M. Erlander, D. Cohen, J. Bridgewater, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.

J. Hainsworth, H. Burris, D. Spigel, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The need for validation of MI GPSai in patients with CUP: Comment on: “Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type” by J Abraham et al.

F. Greco, 2021, Translational oncology.

Cancer of unknown primary site: improved patient management with molecular and immunohistochemical diagnosis.

F. Greco, A. Greco, 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Cancer of unknown primary site: evolving understanding and management of patients.

F. Greco, 2012, Clinical advances in hematology & oncology : H&O.

The evolving role of molecular diagnosis of cancer types and subtypes: stay tuned

F. Greco, 2011 .

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.

J. Hainsworth, D. Spigel, F. Greco, 2009, The oncologist.

Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site

J. Hainsworth, K. Yost, D. Spigel, 2005, Cancer.

Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study.

J. Hainsworth, H. Burris, F. Greco, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carcinoma of unknown primary site

J. Hainsworth, H. Burris, F. Greco, 2000, Cancer.

Phase I study of MVE-2 evaluating toxicity and biologic response modification capability

J. Hainsworth, W. Grosh, F. Greco, 2004, Cancer Immunology, Immunotherapy.

MODIFICATION OF HUMAN NATURAL CELL-MEDIATED CYTOTOXICITY BY MVE-2

F. Greco, J. T. Forbes, A. Luck, 1982 .

Lithium and immune function in man.

F. Greco, 1980, Advances in experimental medicine and biology.

Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non‐hodgkin's lymphoma

J. Hainsworth, F. Greco, M. McMaster, 1991, Cancer.

Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung cancer

J. Hainsworth, F. Greco, 1997 .

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

J. Hainsworth, J. Strupp, D. Johnson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Etoposide phosphate or etoposide with cisplatin in the treatment of small cell lung cancer: randomized phase II trial.

J. Hainsworth, F. Greco, 1995, Lung cancer.

Neuroendocrine carcinoma of unknown primary site.

J. Hainsworth, D. Spigel, F. Greco, 2009, Seminars in oncology.

Review: Small-Cell Lung Cancer: Current Perspectives

F. Greco, David H. Johnson, 1987 .

Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary

M. Overman, G. Varadhachary, Xuemei Wang, 2021, Clinical Cancer Research.

Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.

J. Hainsworth, H. Burris, T. Mekhail, 2018, Lung cancer.

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.

J. Hainsworth, H. Burris, D. Spigel, 2012, Lung cancer.

Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network

J. Hainsworth, H. Burris, D. Yardley, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors.

Suzanne F. Jones, J. Bendell, H. Burris, 2011, Clinical advances in hematology & oncology : H&O.

Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.

J. Hainsworth, F. Greco, John D Hainsworth, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab a s F irst-Line a nd M aintenance T herapy f or Patients W ith I ndolent N on-Hodgkin's L ymphoma

J. Hainsworth, H. Burris, D. Yardley, 2002 .

A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2011, Clinical advances in hematology & oncology : H&O.

Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.

J. Hainsworth, N. Robert, N. Senzer, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non–small cell lung cancer: A randomized, placebo‐controlled phase 2 trial with correlated serum proteomic signatures

J. Hainsworth, H. Burris, D. Spigel, 2018, Cancer.

Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.

J. Hainsworth, D. Spigel, F. Greco, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy in metastatic and locally advanced non-small cell lung cancer.

D. Spigel, F. Greco, 2003, Seminars in surgical oncology.

Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network.

J. Hainsworth, F. Greco, J. Gray, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer.

F. Greco, F A Greco, 2001, Lung cancer.

Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte‐colony stimulating factor) in the treatment of patients with advanced, refractory cancer

J. Hainsworth, H. Burris, F. Greco, 1999, Cancer.

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial.

J. Hainsworth, W. Urba, M. Thomas, 1998, European journal of cancer.

One-hour paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

J. Hainsworth, F. Greco, 1998, Oncology.

Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience.

J. Hainsworth, H. Burris, F. Greco, 2001, Seminars in oncology.

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

J. Crawford, D. Johnson, F. Greco, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial.

J. Hainsworth, F. Greco, T. Burish, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abnormal erythrocyte anion exchange in Alzheimer disease.

A. K. Solomon, A. Satlin, F. Greco, 2000, Archives of pathology & laboratory medicine.

Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

B. McAneny, F. Greco, L. Schwartzberg, 1998, British journal of haematology.

Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment.

M. Carey, F. Greco, T. Burish, 1987, Journal of consulting and clinical psychology.

Multiagent chemotherapy in advanced ovarian carcinoma

F. Greco, D. Brenner, 1985 .

Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome.

D. Johnson, F. Greco, A. List, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients (pts) with HER2-positive metastatic breast cancer (MBC)

J. Hainsworth, H. Burris, J. Infante, 2008 .

Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

L J Liang, F M Muggia, S. Groshen, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Diagnosis of the Tissue of Origin in Cancer of Unknown Primary Site: Useful in Patient Management

F. Greco, 2013, Current Treatment Options in Oncology.

Molecular Classification of Cancers of Unknown Primary Site

M. Erlander, F. Greco, 2009, Molecular Diagnosis & Therapy.

Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.

Denise, Yardley, Xiao-Jun Ma, 2010, The oncologist.

Evolving understanding and current management of patients with cancer of unknown primary site

F. Greco, 2010 .

International Consensus on the Initial Diagnostic Workup of Cancer of Unknown Primary.

M. Esteller, I. Nagtegaal, N. Pavlidis, 2022, Critical reviews in oncology/hematology.

Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial

J. Hainsworth, K. Fizazi, N. Penel, 2015, Cancer.

Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2009, Clinical breast cancer.

One-hour paclitaxel infusions: review of safety and efficacy.

J. Hainsworth, M. Thomas, F. Greco, 1999, The cancer journal from Scientific American.

Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.

J. Hainsworth, H. Burris, D. Spigel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).

J. Hainsworth, H. Burris, D. Spigel, 2018, Lung cancer.

P-460 Results of a phase 2 trial of HGS-ETR1 (agonistic humanmonoclonal antibody to TRAIL receptor 1) in subjects with relapsedlrecurrent non-small cell lung cancer (NSCLC)

K. Kelly, J. Crawford, Y. Oh, 2005 .

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer.

K. Kelly, J. Crawford, Y. Oh, 2008, Lung cancer.

Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium.

J. Hainsworth, F. Greco, A. Meluch, 2000, European journal of cancer.

Topotecan: Weekly intravenous (IV) schedule similar to standard 5-day IV schedule as second-line therapy for relapsed small cell lung cancer (SCLC)-A Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, D. Spigel, F. Greco, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer of unknown primary or unrecognized adnexal skin primary carcinoma? Limitations of gene expression profiling diagnosis.

F. Greco, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.

J. Hainsworth, D. Johnson, F. Greco, 1992, Seminars in oncology.

Human breast cancer and estrogen receptors.

F. Greco, 1978, Journal of the Tennessee Medical Association.

Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.

J. Hainsworth, D. Johnson, F. Greco, 1984, Cancer research.

Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.

H. Cohen, C. Perez, L. Einhorn, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer with skeletal metastases at initial diagnosis: Distinctive clinical characteristics and favorable prognosis

J. Hainsworth, F. Greco, David H. Johnson, 1986, Cancer.

Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural block.

J. Hainsworth, J. Murray, F. Greco, 1983, The American journal of medicine.

Effect of lithium carbonate on the neutropenia caused by chemotherapy: a preliminary clinical trial.

H. Brereton, F. Greco, 1977, Oncology.

Lithium attenuation of chemotherapy-induced granulocytopenia: statistical and clinical significance?

F. Greco, 1980, Advances in experimental medicine and biology.

Chronic daily administration of oral etoposide.

D. Johnson, F. Greco, J. Hainsworth, 1990, Seminars in oncology.

Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patients.

W. Dupont, F. Greco, J. Greer, 1986, The American journal of medicine.

Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion.

F. Greco, J. Gober, J. Gay, 1980, Cancer treatment reviews.

Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.

L. Burnett, H. Jones, F. Greco, 1987, Gynecologic oncology.

A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2008, Clinical breast cancer.

Rituximab with short duration chemotherapy followed by 90Y ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: Update of a Minnie Pearl Cancer Research Network phase II trial

J. Hainsworth, K. Yost, D. Spigel, 2005 .

Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centers.

J. Hainsworth, F. Greco, L. Campos, 1998, American journal of clinical oncology.

A brief‐duration combination chemotherapy for elderly patients with poor‐prognosis non‐Hodgkin's lymphoma

J. Hainsworth, F. Greco, M. McMaster, 1991, Cancer.

Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer.

J. Hainsworth, H. Burris, F. Greco, 2000, Seminars in oncology.

Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma

J. Hainsworth, D. Spigel, F. Greco, 2008, Cancer.

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

J. Hainsworth, F. Greco, L. Schwartzberg, 1997, Bone Marrow Transplantation.

Immunologic function in man receiving lithium carbonate.

D. Murphy, F. Greco, R. Oldham, 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

What is the role of novel taxanes in non-small-cell lung cancer?

D. Spigel, F. Greco, 2008, Clinical lung cancer.

Phase II trial of rituximab and short duration chemotherapy followed by 90Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: A Minnie Pearl Cancer Research Network phase II trial

J. Hainsworth, D. Spigel, F. Greco, 2004 .

High-dose methotrexate in combination chemotherapy for small cell lung cancer.

F. Greco, R. Oldham, K. Hande, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.

F. Greco, R. Oldham, J. Knost, 1981, Cancer treatment reports.

A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib.

Mikhail Teverovskiy, Angeliki Kotsianti, David Verbel, 2009, European journal of cancer.

Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, K. Yost, D. Spigel, 2006, Clinical genitourinary cancer.

The role of weekly docetaxel in the treatment of advanced non-small-cell lung cancer.

J. Hainsworth, F. Greco, 2002, Clinical lung cancer.

A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

Suzanne F. Jones, F. Gao, R. Govindan, 2007, Clinical Cancer Research.

Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients.

Suzanne F. Jones, J. Hainsworth, F. Greco, 2003, Clinical lung cancer.

Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.

J. Hainsworth, J. Bendell, H. Burris, 2012, Clinical colorectal cancer.

Double-blind randomized phase II trial of carboplatin and pemetrexed with or without OGX-427 in patients with previously untreated stage IV non-squamous non-small-cell lung cancer (NSCLC): The Spruce Clinical Trial.

J. Hainsworth, H. Burris, D. Spigel, 2013 .

Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.

J. Reeves, I. Flinn, J. Hainsworth, 2014, Clinical lymphoma, myeloma & leukemia.

Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer

J. Hainsworth, F. Greco, R. Workman, 1983, Cancer.

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma

J. Hainsworth, H. Burris, F. Greco, 2002, Cancer.

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.

A. Bartolucci, J. Crawford, D. Johnson, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung.

D. Johnson, F. Greco, K. Hande, 1985, Cancer treatment reports.

Treatment options for patients with relapsed small cell lung cancer

F. Greco, 1993 .

Combined modality therapy with radiation therapy (RT), chemotherapy, bevacizumab, and erlotinib in the treatment of patients (pts) with locally advanced squamous carcinoma of the head and neck.

J. Hainsworth, H. Burris, D. Spigel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer.

Michael Thomas, S. Thongprasert, P. Sunpaweravong, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination Chemotherapy with Gemcitabine and Vinorelbine in the Treatment of Patients with Relapsed or Refractory Small Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network

J. Hainsworth, F. Greco, J. B. Erland, 2003, Cancer investigation.

Paclitaxel, carboplatin, and extended-schedule oral etoposide for small-cell lung cancer.

J. Hainsworth, M. Thomas, F. Greco, 1998, Oncology.

Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma

J. Hainsworth, H. Burris, F. Greco, 2001, Cancer.

Patterns of failure in combined chemotherapy and radiotherapy for limited small cell lung cancer: Southeastern Cancer Study Group experience.

C. Perez, F. Greco, R. Birch, 1988, NCI monographs : a publication of the National Cancer Institute.

Aggressive non-Hodgkin's lymphoma in the elderly: an effective, well-tolerated treatment regimen containing extended-schedule etoposide.

J. Hainsworth, F. Greco, J. Greer, 1994, Journal of the National Cancer Institute.

Kinetics of Chloride-Bicarbonate Exchange Across the Human Red Blood Cell Membrane

A. K. Solomon, F. Greco, 1997, The Journal of Membrane Biology.

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.

M Buyse, M. Buyse, R. Schilsky, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine

Suzanne F. Jones, J. Hainsworth, J. Bendell, 2011, Cancer Chemotherapy and Pharmacology.

Oral Etoposide in Lymphoma

F. Greco, 2012, Drugs.

Hexamethylmelamine in mustard-resistant ovarian adenocarcinoma.

F. Greco, R. Birch, G. Omura, 1981, Cancer treatment reports.

Etoposide-induced hepatic injury: a potential complication of high-dose therapy.

D. Johnson, F. Greco, S. Wolff, 1983, Cancer treatment reports.

A comparison of hexamethylmelamine (altretamine), cyclophosphamide, doxorubicin, and cisplatin (H-CAP) vs. cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced ovarian cancer.

D. Johnson, F. Greco, J. Hainsworth, 1991, Cancer treatment reviews.

High‐dose, brief duration, multiagent chemotherapy for metastatic breast cancer

J. Hainsworth, F. Greco, P. Murphy, 1994, Cancer.

High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer

F. Greco, R. Oldham, K. Hande, 2004, Cancer Chemotherapy and Pharmacology.

Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.

J. Hainsworth, D. Johnson, F. Greco, 1992, Oncology.

Klinefelter's syndrome and mediastinal germ cell neoplasms.

F. Greco, R. Richardson, W. Curry, 1981, The Journal of urology.

Carcinoma of unknown primary site (CUP): Outcomes in patients with a colorectal molecular profile treated with site-specific chemotherapy.

J. Hainsworth, G. Varadhachary, D. Spigel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non–small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2

J. Hainsworth, H. Burris, D. Spigel, 2018, Cancer.

Therapy of adenocarcinoma of unknown primary: are we making progress?

F. Greco, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.

Howard, J. Hainsworth, R. Hermann, 2004, The oncologist.

Taxane-based chemotherapy for patients with carcinoma of unknown primary site.

J. Hainsworth, H. Burris, F. Greco, 2001, Cancer journal.

Advanced Ovarian Cancer: Brief Intensive Combination Chemotherapy and Second-Look Operation

L. Burnett, F. Greco, R. Oldham, 1981, Obstetrics and gynecology.

Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by maintenance bevacizumab (B) in the treatment (tx) of limited-stage small cell lung cancer (LS-SCLC): Update of a phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, D. Spigel, F. Greco, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2009, Clinical breast cancer.

Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience.

L. Einhorn, M. Troner, F. Greco, 1986, Cancer treatment reports.

Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, H. Burris, M. Thomas, 2000, Cancer journal.

Confirmation of non-small cell lung cancer (NSCLC) diagnosis using ALK testing and genetic profiling in patients presenting with carcinoma of unknown primary site (CUP).

J. Hainsworth, D. Spigel, F. Greco, 2013 .

Docetaxel and Epirubicin as First-Line Treatment for Patients with Metastatic Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

J. Hainsworth, D. Yardley, D. Spigel, 2006, Cancer investigation.

Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.

C. Presant, J. Carpenter, A. Bartolucci, 1986, Cancer treatment reports.

Limited Stage Small Cell Lung Cancer: Analysis of Clinical Prognostic Factors

Robert V Farese, J. Hainsworth, W. Vaughn, 1987, Southern medical journal.

Acute nonlymphocytic leukemia after treatment of small cell lung cancer.

D. Johnson, F. Greco, A. List, 1986, The American journal of medicine.

Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer

M. Buyse, A. Piga, C. Köhne, 2001, British Journal of Cancer.

Docetaxel (Taxotere) administered in weekly schedules.

F. Greco, 1999, Seminars in oncology.

Phase II study of NK012 in relapsed small cell lung cancer.

J. Hainsworth, J. Bendell, H. Burris, 2011, Journal of Clinical Oncology.

Management of CNS metastases in small cell lung cancer: a consensus report

D. Ettinger, H. Earl, P. Postmus, 1989 .

Serum Lactate Dehydrogenase and Bone Marrow Metastases in Small-Cell Carcinoma of the Lung

F. Hirsch, A. Pedersen, F. Greco, 1985 .

The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site.

J. Hainsworth, F. Greco, 1989, Seminars in oncology.

A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2002, The oncologist.

Bevacizumab plus erlotinib in patients (pts) with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, D. Spigel, F. Greco, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan, carboplatin, and imatinib in extensive stage small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, H. Burris, D. Yardley, 2004, Journal of Clinical Oncology.

Phase II study of vinblastine in advanced refractory ovarian carcinoma.

W. Grosh, L. Burnett, H. Jones, 1983, American Journal of Clinical Oncology.

J. Hainsworth, D. Spigel, F. Greco, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Poorly Differentiated Neoplasms of Unknown Primary Site: Diagnostic Usefulness of a Molecular Cancer Classifier Assay

J. Hainsworth, D. Spigel, F. Greco, 2015, Molecular Diagnosis & Therapy.

The impact of molecular testing on treatment of cancer of unknown primary origin.

F. Greco, 2013, Oncology.

Limited stage small cell lung cancer.

F. Greco, J. Knost, 1980, Journal of the Tennessee Medical Association.

Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized prospective phase II trial.

J. Hainsworth, H. Burris, F. Greco, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single agent gefitinib in poor performance status patients with previously untreated advanced non-small cell lung cancer: A Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, H. Burris, M. Thomas, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent paclitaxel/carboplatin/infusional 5-FU/radiation therapy (RT) with or without subsequent esophageal resection in patients with localized esophageal cancer: A Minnie Pearl Cancer Research Network trial

J. Hainsworth, R. Hermann, D. Spigel, 2005 .

Orally Dosing Furosemide to Approximate Continuous Infusion.

F. Greco, Erin M Spyropoulos, Nicholas J Simms, 2017, American Journal of Medicine.

Small-Cell Lung Cancer : Treatment Progress and Prospects

F. Greco, 2017 .

First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)

J. Hainsworth, H. Burris, T. Mekhail, 2017, Cancer investigation.

Day 1 pegfilgrastim with dose dense adjuvant chemotherapy: Amelioration of docetaxel neutropenia but not that of doxorubicin/cyclophosphamide. Results from a Sarah Cannon Research Institute pilot study

J. Hainsworth, H. Burris, D. Yardley, 2005 .

Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor.

F. Greco, J. M. Barrett, R. Richardson, 1980, Obstetrics and gynecology.

Polar, aprotic solvents and the hydrophobic effect

F. Greco, 1984 .

Phase II trial of high-dose weekly topotecan in patients with relapsed small-cell lung cancer (SCLC)

J. Hainsworth, H. Burris, J. Infante, 2008 .

Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).

J. Hainsworth, H. Burris, D. Spigel, 2012, Lung cancer.

Poorly differentiated carcinoma and germ cell tumors.

J. Hainsworth, F. Greco, 1991, Hematology/oncology clinics of North America.

Phase II trial of radiation therapy/temozolomide followed by temozolomide/sorafenib in the first-line treatment of glioblastoma multiforme (GBM).

J. Hainsworth, H. Burris, D. Spigel, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

211 – Cancer of Unknown Primary Origin

J. Hainsworth, F. Greco, 2012 .

Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine.

W. E. Jordan, J. Hainsworth, P. Engstrom, 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine INVITED

J. Hainsworth, F. Greco, 2018 .

Unknown primary cancer (UPC): Accuracy of tissue of origin prediction by molecular profiling.

M. Erlander, J. Hainsworth, D. Spigel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer of unknown primary site.

W. E. Jordan, J. Hainsworth, P. Engstrom, 2010, Seminars in oncology.

Serum neuron-specific enolase in metastatic Merkel cell tumors.

W. Grosh, D. Johnson, F. Greco, 1985, Medical and pediatric oncology.

Bevacizumab and erlotinib in the treatment of patients (pts) with metastatic carcinoma of unknown primary site: A Sarah Cannon Research Institute phase II trial

J. Hainsworth, M. Thomas, D. Spigel, 2005 .

A randomized phase II trial of oral topotecan versus docetaxel in the second-line treatment of non-small-cell lung cancer.

Suzanne F. Jones, H. Burris, J. Infante, 2008, Clinical lung cancer.

A phase II trial of VNP40101M in patients with relapsed or refractory small cell lung cancer (SCLC) with or without brain metastases

S. Gettinger, T. Mekhail, D. Spigel, 2007 .

Acute nonlymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia: Clinical studies

H. Gralnick, H. Brereton, F. Greco, 1979, Cancer.

Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2003, Oncology.

A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009).

J. Hainsworth, H. Burris, N. Peacock, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC).

J. Hainsworth, J. Sosman, D. Spigel, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unusual survival after pulmonary artery sarcoma.

F. Greco, R. Oldham, A. Glick, 1981, Southern medical journal (Birmingham, Ala. Print).

Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.

J. Hainsworth, F. Greco, R. Birch, 1986, Cancer treatment reports.

Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.

F. Greco, P. Loehrer, R. Birch, 1986, Cancer treatment reports.

Phase II studies in resistant small cell lung cancer

F. Greco, R. Oldham, K. Hande, 1979 .

Small cell lung cancer.

F. Greco, R. Oldham, 1990, British medical journal.

Treatment of small cell lung cancer: another study on alternating chemotherapy.

D. Johnson, F. Greco, 1987, European journal of cancer & clinical oncology.

A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.

J. Hainsworth, F. Greco, R. Birch, 1997, Seminars in Oncology.

Oat-cell carcinoma of the lung with carcinomatous meningitis.

F. Greco, M. Fer, 1978, The New England journal of medicine.

Value of radiation therapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation

H. Cohen, C. Perez, L. Einhorn, 1984 .

Rationale for chemotherapy for patients with advanced non-small-cell lung cancer.

F. Greco, 1986, Seminars in oncology.

Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.

J. Hainsworth, H. Burris, D. Spigel, 2004, The Oncologist.

A preliminary retrospective analysis of weekly topotecan in recurrent small-cell lung cancer

F. Greco, J. Eckardt, V. Kasturi, 2004 .

P-576 Phase II trial of weekly topotecan in the second-line treatment of small cell lung cancer

J. Hainsworth, H. Burris, D. Yardley, 2003 .

Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.

J. Hainsworth, F. Greco, 1996, Seminars in Oncology.

Carcinoma of unknown primary site with unfavorable characteristics: Survival of 396 patients after treatment with five consecutive phase II trials by the Minnie Pearl Cancer Research Network

J. Hainsworth, R. Hermann, F. Greco, 2004 .

Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2003, Oncology.

A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.

J. Hainsworth, D. Yardley, D. Spigel, 2008, Clinical breast cancer.

Letter: Loss of symptoms of pulmonary hypertrophic osteoarthropathy after laparotomy.

I. Kushner, F. Greco, 1974, Annals of internal medicine.

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.

J. Hainsworth, D. Spigel, F. Greco, 2009, The oncologist.

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients (pts) with carcinoma of unknown primary site (CUP): Results of a prospective Sarah Cannon Research Institute (SCRI) trial.

M. Erlander, J. Hainsworth, C. Schnabel, 2012 .

9005 Vandetanib versus erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

S. Thongprasert, P. Sunpaweravong, D. Ferry, 2009 .

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site

J. Hainsworth, H. Burris, D. Spigel, 2010, Cancer.

Sorafenib and everolimus (RAD001) in the treatment of patients with advanced clear cell renal carcinoma (RCC): A Sarah Cannon Research Institute phase I/II trial.

J. Hainsworth, H. Burris, F. Greco, 2011, Journal of Clinical Oncology.

Phase II evaluation of spirogermanium in advanced ovarian carcinoma.

L. Burnett, S. Tipping, F. Greco, 1983, Cancer treatment reports.

Carcinoma of Unknown Primary Site: Outcomes in Patients with a Colorectal Molecular Profile Treated with Site Specific Chemotherapy

J. Hainsworth, G. Varadhachary, D. Spigel, 2012 .

Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial.

J. Hainsworth, F. Greco, 1997, Seminars in oncology.

Weekly bortezomib in the treatment of patients (pts) with previously treated multiple myeloma: A phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, R. Hermann, D. Spigel, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site.

D. Johnson, F. Greco, J. Hainsworth, 1992, Seminars in oncology.

Carcinoma of unknown primary site.

J. Hainsworth, F. Greco, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I trial of protracted oral fixed‐dose temozolomide

Suzanne F. Jones, J. Hainsworth, F. Greco, 2005, Cancer.

One-hour paclitaxel infusion schedules: a phase I/II comparative trial.

J. Hainsworth, F. Greco, 1995, Seminars in oncology.

Long-Term Followup of Patients with Follicular Lymphoma (FL) Treated with Two Years of Maintenance Rituximab: Response to Rituximab Retreatment at Progression.

J. Hainsworth, D. Spigel, F. Greco, 2006 .